Pascal Jézéquel

4.8k total citations
64 papers, 2.4k citations indexed

About

Pascal Jézéquel is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Pascal Jézéquel has authored 64 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 16 papers in Oncology. Recurrent topics in Pascal Jézéquel's work include Breast Cancer Treatment Studies (10 papers), Gene expression and cancer classification (8 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Pascal Jézéquel is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Gene expression and cancer classification (8 papers) and Radiomics and Machine Learning in Medical Imaging (7 papers). Pascal Jézéquel collaborates with scholars based in France, United States and Italy. Pascal Jézéquel's co-authors include Mario Campone, Catherine Guérin‐Charbonnel, L. Campion, Wilfried Gouraud, Gabriel Ricolleau, Hamza Lasla, Delphine Loussouarn, Christophe Leux, Philippe Juin and Sophie Barillé‐Nion and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Bioinformatics.

In The Last Decade

Pascal Jézéquel

63 papers receiving 2.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Pascal Jézéquel 1.5k 789 663 430 307 64 2.4k
Anne M. Øyan 1.6k 1.1× 809 1.0× 769 1.2× 410 1.0× 341 1.1× 75 2.9k
Wilfried Gouraud 1.3k 0.9× 714 0.9× 537 0.8× 333 0.8× 523 1.7× 30 1.8k
Randall Schreck 1.5k 1.0× 686 0.9× 469 0.7× 318 0.7× 151 0.5× 13 2.3k
Kakajan Komurov 1.7k 1.2× 938 1.2× 603 0.9× 214 0.5× 241 0.8× 44 2.5k
Catherine Guérin‐Charbonnel 1.7k 1.2× 951 1.2× 569 0.9× 365 0.8× 906 3.0× 48 2.4k
Keith Orford 1.9k 1.3× 938 1.2× 446 0.7× 261 0.6× 275 0.9× 36 2.7k
Barry R. Davies 2.1k 1.5× 1.0k 1.3× 584 0.9× 735 1.7× 114 0.4× 99 3.4k
Leonard Girnita 2.5k 1.8× 781 1.0× 898 1.4× 352 0.8× 114 0.4× 72 3.7k
Josh Lauring 1.4k 1.0× 515 0.7× 510 0.8× 272 0.6× 147 0.5× 42 2.0k
Aixiang Jiang 1.1k 0.8× 1.2k 1.6× 723 1.1× 411 1.0× 149 0.5× 48 2.7k

Countries citing papers authored by Pascal Jézéquel

Since Specialization
Citations

This map shows the geographic impact of Pascal Jézéquel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Jézéquel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Jézéquel more than expected).

Fields of papers citing papers by Pascal Jézéquel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Jézéquel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Jézéquel. The network helps show where Pascal Jézéquel may publish in the future.

Co-authorship network of co-authors of Pascal Jézéquel

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Jézéquel. A scholar is included among the top collaborators of Pascal Jézéquel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Jézéquel. Pascal Jézéquel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clavreul, Anne, Catherine Guette, Hamza Lasla, et al.. (2024). Proteomics of tumor and serum samples from isocitrate dehydrogenase‐wildtype glioblastoma patients: is the detoxification of reactive oxygen species associated with shorter survival?. Molecular Oncology. 18(11). 2783–2800. 5 indexed citations
2.
Jézéquel, Pascal, Hamza Lasla, Wilfried Gouraud, et al.. (2024). Mesenchymal-like immune-altered is the fourth robust triple-negative breast cancer molecular subtype. Breast Cancer. 31(5). 825–840. 3 indexed citations
3.
Basseville, Agnès, Wilfried Gouraud, Hamza Lasla, et al.. (2022). Brain Neural Progenitors are New Predictive Biomarkers for Breast Cancer Hormonotherapy. Cancer Research Communications. 2(8). 857–869. 2 indexed citations
4.
Ferrer, Ludovic, Caroline Rousseau, M. Lacombe, et al.. (2022). Deformable image registration with deep network priors: a study on longitudinal PET images. Physics in Medicine and Biology. 67(15). 155011–155011. 4 indexed citations
5.
Rousseau, Caroline, Ludovic Ferrer, M. Lacombe, et al.. (2021). Automatic Segmentation of Metastatic Breast Cancer Lesions on 18F-FDG PET/CT Longitudinal Acquisitions for Treatment Response Assessment. Cancers. 14(1). 101–101. 18 indexed citations
6.
Jézéquel, Pascal, Wilfried Gouraud, Catherine Guérin‐Charbonnel, et al.. (2021). bc-GenExMiner 4.5: new mining module computes breast cancer differential gene expression analyses. Database. 2021. 127 indexed citations
7.
Martin, E., Claude Lemarié, Pascal Jézéquel, et al.. (2021). 156P Impact of HER2 status (HER2-low versus HER2-0) on complete histologic response after neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC). Annals of Oncology. 32. S428–S429. 3 indexed citations
8.
Jézéquel, Pascal, et al.. (2020). A partial graphical model with a structural prior on the direct links\n between predictors and responses. arXiv (Cornell University). 1 indexed citations
9.
Romagnoli, Mathilde, Nora D. Mineva, Sophie Barillé‐Nion, et al.. (2016). miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells. Breast Cancer Research. 18(1). 40–40. 43 indexed citations
10.
Campone, Mario, Isabelle Valo, Pascal Jézéquel, et al.. (2015). Prediction of Recurrence and Survival for Triple-Negative Breast Cancer (TNBC) by a Protein Signature in Tissue Samples. Molecular & Cellular Proteomics. 14(11). 2936–2946. 41 indexed citations
11.
Jézéquel, Pascal, Hamza Lasla, Wilfried Gouraud, et al.. (2015). Gene-expression signature functional annotation of breast cancer tumours in function of age. BMC Medical Genomics. 8(1). 80–80. 6 indexed citations
12.
Jézéquel, Pascal, Delphine Loussouarn, Catherine Guérin‐Charbonnel, et al.. (2015). Gene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune response. Breast Cancer Research. 17(1). 43–43. 228 indexed citations
13.
Jézéquel, Pascal, Philippe Juin, & Mario Campone. (2014). « Bioinfomique » : un nouveau mot pour un nouveau champ de recherche. Bulletin du Cancer. 101(2). 118–119. 1 indexed citations
14.
Malleter, Marine, Sébastien Tauzin, Alban Bessede, et al.. (2013). CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast Cancer. Cancer Research. 73(22). 6711–6721. 69 indexed citations
15.
Romagnoli, Mathilde, Karine Belguise, Ziyang Yu, et al.. (2012). Epithelial-to-Mesenchymal Transition Induced by TGF-β1 Is Mediated by Blimp-1–Dependent Repression of BMP-5. Cancer Research. 72(23). 6268–6278. 79 indexed citations
16.
Campone, Mario, Cécile Couriaud, Morgan Grau, et al.. (2011). c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1. Molecular Cancer. 10(1). 110–110. 34 indexed citations
17.
Hamaï, Ahmed, Pascale Pignon, Isabelle Raimbaud, et al.. (2011). Antibody Responses to NY-ESO-1 in Primary Breast Cancer Identify a Subtype Target for Immunotherapy. PLoS ONE. 6(6). e21129–e21129. 21 indexed citations
18.
19.
Campone, Mario, L. Campion, Wilfried Gouraud, et al.. (2007). Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen. Breast Cancer Research and Treatment. 109(3). 491–501. 34 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne M. Øyan Breakdown of academic impact, for papers by Wilfried Gouraud Breakdown of academic impact, for papers by Randall Schreck Breakdown of academic impact, for papers by Kakajan Komurov Breakdown of academic impact, for papers by Catherine Guérin‐Charbonnel Breakdown of academic impact, for papers by Keith Orford Breakdown of academic impact, for papers by Barry R. Davies Breakdown of academic impact, for papers by Leonard Girnita Breakdown of academic impact, for papers by Josh Lauring Breakdown of academic impact, for papers by Aixiang Jiang
Rankless by CCL
2026